MAPK1 and breast cancer: Conversely, the lower m6A levels in ERK2 and PRF1 transcripts in BC patients were accompanied by significantly higher ERK2 (P = 0.0005, q = 0.0007) and PRF1 (P = 0.0126, q = 0.0106) mRNA levels in BC patients compared to controls.